"regCodeExt","metaCondition","condition","conditionCode","context","contextCode","regName","variant","regCode","component","day","cycleTaken","cycleLength","noCycles","branchInfo","Radio.Therapy.","continuous","noCycles_Original","regString","shortString"
"100.59.1510.1","Thoraic Oncology","Non-small cell lung cancer, MET-mutated",100,"Metastatic disease, all lines of therapy",59,"Capmatinib monotherapy",1,1510,"Capmatinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;1.Capmatinib;","1.capmatinib;1.capmatinib;"
"100.59.1511.1","Thoraic Oncology","Non-small cell lung cancer, MET-mutated",100,"Metastatic disease, all lines of therapy",59,"Tepotinib monotherapy",1,1511,"Tepotinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;1.Tepotinib;","1.tepotinib;1.tepotinib;"
"101.59.1512.1","Thoraic Oncology","Non-small cell lung cancer, RET-positive",101,"Metastatic disease, all lines of therapy",59,"Pralsetinib monotherapy",1,1512,"Pralsetinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;1.Pralsetinib;","1.pralsetinib;1.pralsetinib;"
"101.59.1513.1","Thoraic Oncology","Non-small cell lung cancer, RET-positive",101,"Metastatic disease, all lines of therapy",59,"Selpercatinib monotherapy",1,1513,"Selpercatinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;1.Selpercatinib;","1.selpercatinib;1.selpercatinib;"
"1011.59.1516.1","Thoraic Oncology","Non-small cell lung cancer, ROS1-positive",1011,"Advanced or metastatic disease, ROS1 inhibitor-naive",59,"Entrectinib monotherapy",1,1516,"Entrectinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;1.Entrectinib;","1.entrectinib;1.entrectinib;"
"102.59.1519.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"All lines of therapy",59,"Teniposide Monotherapy",1,1519,"Teniposide","1","",14,3,"","",TRUE,"Cont.","14.Teniposide;14.Teniposide;","14.teniposide;14.teniposide;"
"102.59.1523.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"EGFR-mutated, all lines of therapy",59,"Cisplatin, Gefitinib, Pemetrexed",1,1523,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","1.Cisplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Cisplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.cisplatin;0.gefitinib;0.pemetrexed;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;"
"102.59.1525.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"EGFR-mutated, all lines of therapy",59,"Gefitinib, Nedaplatin, Pemetrexed",1,1525,"Gefitinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Gefitinib;0.Nedaplatin;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;0.Nedaplatin;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.gefitinib;0.nedaplatin;0.pemetrexed;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;"
"103.62.1531.2","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, definitive chemoradiotherapy",62,"Cisplatin & Etoposide (EP)",2,1531,"Cisplatin","1","",28,3,"","X",TRUE,"Cont.","26.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;26.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","26.cisplatin;0.etoposide;1.etoposide;1.etoposide;"
"103.63.1534.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",63,"Belotecan & Cisplatin",1,1534,"Belotecan","1,2,3,4","",21,3,"","",TRUE,"Cont.","18.Belotecan;0.Cisplatin;1.Belotecan;1.Belotecan;1.Belotecan;18.Belotecan;0.Cisplatin;1.Belotecan;1.Belotecan;1.Belotecan;","18.belotecan;0.cisplatin;1.belotecan;1.belotecan;1.belotecan;"
"103.63.1535.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",63,"Carboplatin & Etoposide (CE)",1,1535,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","17.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;17.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","17.carboplatin;0.etoposide;1.etoposide;1.etoposide;1.etoposide;1.etoposide;"
"103.65.1536.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",65,"Carboplatin & Etoposide (CE) & Atezolizumab",1,1536,"Atezolizumab","1","",21,3,"","",TRUE,"Cont.","19.Atezolizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Atezolizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.atezolizumab;0.carboplatin;0.etoposide;1.etoposide;1.etoposide;"
"103.65.1537.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",65,"Carboplatin & Etoposide (CE) & Bevacizumab",1,1537,"Bevacizumab","1","",21,3,"","",FALSE,"4","19.Bevacizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Bevacizumab;0.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.bevacizumab;0.carboplatin;0.etoposide;1.etoposide;1.etoposide;"
"103.65.1538.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",65,"Carboplatin & Etoposide (CE) & Durvalumab",1,1538,"Carboplatin","1","",21,3,"","",FALSE,"4","19.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;19.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","19.carboplatin;0.durvalumab;0.etoposide;1.etoposide;1.etoposide;"
"103.66.1538.2","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",66,"Carboplatin & Etoposide (CE) & Durvalumab",2,1538,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","26.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;26.Carboplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","26.carboplatin;0.durvalumab;0.etoposide;1.etoposide;1.etoposide;"
"103.67.1539.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",67,"Carboplatin & Etoposide (CE) & Serplulimab",1,1539,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","19.Carboplatin;0.Etoposide;0.Serplulimab;1.Etoposide;1.Etoposide;19.Carboplatin;0.Etoposide;0.Serplulimab;1.Etoposide;1.Etoposide;","19.carboplatin;0.etoposide;0.serplulimab;1.etoposide;1.etoposide;"
"103.67.1540.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",67,"Carboplatin & Irinotecan",1,1540,"Carboplatin","1","",21,3,"","",FALSE,"4","21.Carboplatin;0.Irinotecan;21.Carboplatin;0.Irinotecan;","21.carboplatin;0.irinotecan;"
"103.68.1540.2","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",68,"Carboplatin & Irinotecan",2,1540,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","14.Carboplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;14.Carboplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;","14.carboplatin;0.irinotecan;7.irinotecan;7.irinotecan;"
"103.70.1542.2","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",70,"Cisplatin & Etoposide (EP)",2,1542,"Cisplatin","1,2,3","",21,3,"","",TRUE,"Cont.","18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;","18.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.etoposide;"
"103.71.1542.3","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",71,"Cisplatin & Etoposide (EP)",3,1542,"Cisplatin","1,2,3,4","",21,3,"","",FALSE,"4","18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;18.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","18.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;"
"103.72.1542.4","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",72,"Cisplatin & Etoposide (EP)",4,1542,"Cisplatin","2","",21,3,"","",FALSE,"6","19.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;19.Etoposide;1.Cisplatin;0.Etoposide;1.Etoposide;","19.etoposide;1.cisplatin;0.etoposide;1.etoposide;"
"103.73.1542.5","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",73,"Cisplatin & Etoposide (EP)",5,1542,"Cisplatin","1,2,3,4,5","",21,3,"","",FALSE,"4","17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;17.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","17.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;"
"103.74.1543.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",74,"Cisplatin & Etoposide (EP) & Bevacizumab",1,1543,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","19.Bevacizumab;0.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Bevacizumab;0.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.bevacizumab;0.cisplatin;0.etoposide;1.etoposide;1.etoposide;"
"103.74.1544.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",74,"Cisplatin & Etoposide (EP) & Durvalumab",1,1544,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","19.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;19.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","19.cisplatin;0.durvalumab;0.etoposide;1.etoposide;1.etoposide;"
"103.75.1544.2","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",75,"Cisplatin & Etoposide (EP) & Durvalumab",2,1544,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","26.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;26.Cisplatin;0.Durvalumab;0.Etoposide;1.Etoposide;1.Etoposide;","26.cisplatin;0.durvalumab;0.etoposide;1.etoposide;1.etoposide;"
"103.76.1545.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",76,"Cisplatin & Irinotecan (IC)",1,1545,"Cisplatin","1,8","",21,3,"","",TRUE,"Cont.","14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;14.Cisplatin;0.Irinotecan;7.Cisplatin;0.Irinotecan;","14.cisplatin;0.irinotecan;7.cisplatin;0.irinotecan;"
"103.77.1545.2","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",77,"Cisplatin & Irinotecan (IC)",2,1545,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","14.Cisplatin;0.Irinotecan;7.Irinotecan;14.Cisplatin;0.Irinotecan;7.Irinotecan;","14.cisplatin;0.irinotecan;7.irinotecan;"
"103.78.1548.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",78,"IVE",1,1548,"Epirubicin","1","",21,3,"","",TRUE,"Cont.","19.Epirubicin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;19.Epirubicin;0.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;1.Etoposide;0.Ifosfamide;","19.epirubicin;0.etoposide;0.ifosfamide;1.etoposide;0.ifosfamide;1.etoposide;0.ifosfamide;"
"103.78.1549.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",78,"Teniposide monotherapy",1,1549,"Teniposide","1,2,3,4,5","",21,3,"","",TRUE,"Cont.","17.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;17.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;1.Teniposide;","17.teniposide;1.teniposide;1.teniposide;1.teniposide;1.teniposide;"
"103.78.1552.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, maintenance after first-line therapy",78,"Sunitinib monotherapy",1,1552,"Sunitinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","1.sunitinib;1.sunitinib;"
"103.78.1555.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, second-line",78,"Cisplatin, Etoposide, Irinotecan",1,1555,"Carboplatin","1,8","",14,3,"","",FALSE,"5","7.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Irinotecan;7.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;5.Carboplatin;0.Irinotecan;","7.carboplatin;0.etoposide;1.etoposide;1.etoposide;5.carboplatin;0.irinotecan;"
"103.78.1556.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, second-line",78,"Lurbinectedin monotherapy",1,1556,"Lurbinectedin","1","",21,3,"","",TRUE,"Cont.","21.Lurbinectedin;21.Lurbinectedin;","21.lurbinectedin;21.lurbinectedin;"
"103.78.1557.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Bendamustine monotherapy",1,1557,"Bendamustine","1,2","",21,3,"","",TRUE,"Cont.","20.Bendamustine;1.Bendamustine;20.Bendamustine;1.Bendamustine;","20.bendamustine;1.bendamustine;"
"103.78.1558.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"CAV",1,1558,"Cyclophosphamide","1","",21,3,"","",TRUE,"Cont.","21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;21.Cyclophosphamide;0.Doxorubicin;0.Vincristine;","21.cyclophosphamide;0.doxorubicin;0.vincristine;"
"103.78.1561.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Epirubicin & Ifosfamide",1,1561,"Epirubicin","1","",28,3,"","",TRUE,"Cont.","27.Epirubicin;0.Ifosfamide;1.Ifosfamide;27.Epirubicin;0.Ifosfamide;1.Ifosfamide;","27.epirubicin;0.ifosfamide;1.ifosfamide;"
"103.78.1562.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Etoposide monotherapy",1,1562,"Etoposide","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",21,3,"","",TRUE,"Cont.","1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","1.etoposide;1.etoposide;"
"103.78.1564.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Ifosfamide monotherapy",1,1564,"Ifosfamide","1","",21,3,"","",TRUE,"Cont.","21.Ifosfamide;21.Ifosfamide;","21.ifosfamide;21.ifosfamide;"
"103.78.1565.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Ifosfamide & Paclitaxel",1,1565,"Ifosfamide","1,2","",21,3,"","",TRUE,"Cont.","20.Ifosfamide;0.Paclitaxel;1.Ifosfamide;20.Ifosfamide;0.Paclitaxel;1.Ifosfamide;","20.ifosfamide;0.paclitaxel;1.ifosfamide;"
"103.78.1566.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Irinotecan monotherapy",1,1566,"Irinotecan","1,8,15","",21,3,"","",TRUE,"Cont.","7.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;7.Irinotecan;","7.irinotecan;7.irinotecan;"
"103.79.1566.2","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",79,"Irinotecan monotherapy",2,1566,"Irinotecan","1","",21,3,"","",TRUE,"Cont.","21.Irinotecan;21.Irinotecan;","21.irinotecan;21.irinotecan;"
"103.80.1567.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",80,"Paclitaxel monotherapy",1,1567,"Paclitaxel","1","",21,3,"","",TRUE,"Cont.","21.Paclitaxel;21.Paclitaxel;","21.paclitaxel;21.paclitaxel;"
"103.81.1567.2","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",81,"Paclitaxel monotherapy",2,1567,"Paclitaxel","1,8,15,22,29,36","",56,3,"","",TRUE,"Cont.","21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;21.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","21.paclitaxel;7.paclitaxel;7.paclitaxel;7.paclitaxel;7.paclitaxel;7.paclitaxel;"
"103.82.1568.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",82,"Temozolomide monotherapy",1,1568,"Temozolomide","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",28,3,"","",TRUE,"Cont.","8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;8.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","8.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;"
"103.83.1568.2","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",83,"Temozolomide monotherapy",2,1568,"Temozolomide","1,2,3,4,5","",28,3,"","",TRUE,"Cont.","24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;24.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;1.Temozolomide;","24.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;1.temozolomide;"
"103.84.1569.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",84,"Topotecan monotherapy",1,1569,"Topotecan","1,2,3,4,5","",21,3,"","",TRUE,"Cont.","17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;17.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;1.Topotecan;","17.topotecan;1.topotecan;1.topotecan;1.topotecan;1.topotecan;"
"104.86.1571.3","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",86,"PAC",3,1571,"Cisplatin","1,2,3","",21,3,"Cont. Infusion","",FALSE,"3","18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;","18.cisplatin;0.cyclophosphamide;0.doxorubicin;1.cisplatin;0.doxorubicin;1.cisplatin;0.doxorubicin;1.doxorubicin;"
"104.87.1571.4","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",87,"PAC",4,1571,"Cisplatin","1,2,3","",28,3,"Cont. Infusion","",FALSE,"3","25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Cisplatin;0.Doxorubicin;1.Doxorubicin;","25.cisplatin;0.cyclophosphamide;0.doxorubicin;1.cisplatin;0.doxorubicin;1.cisplatin;0.doxorubicin;1.doxorubicin;"
"104.90.1571.3","Thoraic Oncology","Thymoma",104,"Adjuvant therapy",90,"PAC",3,1571,"Cisplatin","1,2,3","",21,3,"Cont. Infusion","",FALSE,"3","18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Cyclophosphamide;1.Cisplatin;0.Cyclophosphamide;1.Cyclophosphamide;18.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Cyclophosphamide;1.Cisplatin;0.Cyclophosphamide;1.Cyclophosphamide;","18.cisplatin;0.cyclophosphamide;0.doxorubicin;1.cisplatin;0.cyclophosphamide;1.cisplatin;0.cyclophosphamide;1.cyclophosphamide;"
"104.91.1571.4","Thoraic Oncology","Thymoma",104,"Adjuvant therapy",91,"PAC",4,1571,"Cisplatin","1,2,3","",28,3,"Cont. Infusion","",FALSE,"3","25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Cyclophosphamide;1.Cisplatin;0.Cyclophosphamide;1.Cyclophosphamide;25.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;0.Cyclophosphamide;1.Cisplatin;0.Cyclophosphamide;1.Cyclophosphamide;","25.cisplatin;0.cyclophosphamide;0.doxorubicin;1.cisplatin;0.cyclophosphamide;1.cisplatin;0.cyclophosphamide;1.cyclophosphamide;"
"104.92.1572.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",92,"ADOC",1,1572,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","18.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;18.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;","18.cisplatin;0.doxorubicin;2.vincristine;1.cyclophosphamide;"
"104.93.1572.2","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",93,"ADOC",2,1572,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","25.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;25.Cisplatin;0.Doxorubicin;2.Vincristine;1.Cyclophosphamide;","25.cisplatin;0.doxorubicin;2.vincristine;1.cyclophosphamide;"
"104.94.1575.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",94,"PAC",1,1575,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;21.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;","21.cisplatin;0.cyclophosphamide;0.doxorubicin;"
"104.94.1576.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, first-line therapy",94,"VIP",1,1576,"Cisplatin","1,2,3,4","",21,3,"","",FALSE,"4","18.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;18.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;1.Cisplatin;0.Etoposide;0.Ifosfamide;","18.cisplatin;0.etoposide;0.ifosfamide;1.cisplatin;0.etoposide;0.ifosfamide;1.cisplatin;0.etoposide;0.ifosfamide;1.cisplatin;0.etoposide;0.ifosfamide;"
"104.94.1577.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",94,"Capecitabine & Gemcitabine",1,1577,"Capecitabine","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14","",21,3,"","",TRUE,"Cont.","8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;8.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;0.Gemcitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;1.Capecitabine;","8.capecitabine;0.gemcitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;0.gemcitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;1.capecitabine;"
"104.94.1578.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",94,"Everolimus monotherapy",1,1578,"Everolimus","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;1.Everolimus;","1.everolimus;1.everolimus;"
"104.94.1580.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",94,"Octreotide monotherapy",1,1580,"Ocreotide","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;1.Ocreotide;","1.ocreotide;1.ocreotide;"
"104.94.1581.1","Thoraic Oncology","Thymoma",104,"Advanced or metastatic disease, subsequent lines of therapy",94,"Sunitinib monotherapy",1,1581,"Sunitinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",42,3,"","",TRUE,"Cont.","15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;15.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;1.Sunitinib;","15.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;1.sunitinib;"
"92.1.1275.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Carboplatin & Paclitaxel (CP) & Nivolumab",1,1275,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Nivolumab;0.Paclitaxel;21.Carboplatin;0.Nivolumab;0.Paclitaxel;","21.carboplatin;0.nivolumab;0.paclitaxel;"
"92.1.1277.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Docetaxel (DC) & Durvalumab",1,1277,"Cisplatin","1","1,2,3",21,0,"","",NA,NA,"0.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;21.Cisplatin;0.Docetaxel;0.Durvalumab;14.Cisplatin;0.Docetaxel;0.Durvalumab;","0.cisplatin;0.docetaxel;0.durvalumab;21.cisplatin;0.docetaxel;0.durvalumab;21.cisplatin;0.docetaxel;0.durvalumab;21.cisplatin;0.docetaxel;0.durvalumab;14.cisplatin;0.docetaxel;0.durvalumab;"
"92.1.1278.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Docetaxel (DC) & Nivolumab",1,1278,"Cisplatin","1","",21,3,"","",FALSE,"3","21.Cisplatin;0.Docetaxel;0.Nivolumab;21.Cisplatin;0.Docetaxel;0.Nivolumab;","21.cisplatin;0.docetaxel;0.nivolumab;"
"92.1.1282.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Vinorelbine (CVb) & Nivolumab",1,1282,"Cisplatin","1","",21,3,"","",FALSE,"3","14.Cisplatin;0.Nivolumab;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Nivolumab;0.Vinorelbine;7.Vinorelbine;","14.cisplatin;0.nivolumab;0.vinorelbine;7.vinorelbine;"
"92.1.1283.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",1,"Atezolizumab monotherapy",1,1283,"Atezolizumab","1","",14,3,"","",TRUE,"Cont.","14.Atezolizumab;14.Atezolizumab;","14.atezolizumab;14.atezolizumab;"
"92.10.1298.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",10,"Carboplatin Monotherapy",1,1298,"Carboplatin","1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 15, 16, 17, 18, 19, 22, 23, 24, 25, 26","",28,1,"","X",FALSE,"1","0.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;3.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;1.Carboplatin;","0.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;3.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;3.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;3.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;1.carboplatin;"
"92.12.1300.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",12,"Cisplatin & Docetaxel (DC)",1,1300,"Cisplatin","1,8,15,22,29,36","",42,1,"","X",FALSE,"1","0.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;","0.cisplatin;0.docetaxel;7.cisplatin;0.docetaxel;7.cisplatin;0.docetaxel;7.cisplatin;0.docetaxel;7.cisplatin;0.docetaxel;7.cisplatin;0.docetaxel;"
"92.13.1300.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",13,"Cisplatin & Docetaxel (DC)",2,1300,"Cisplatin","1,8","",28,2,"","X",FALSE,"2","21.Cisplatin;0.Docetaxel;7.Cisplatin;0.Docetaxel;","21.cisplatin;0.docetaxel;7.cisplatin;0.docetaxel;"
"92.15.1301.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",15,"Cisplatin & Etoposide (EP)",2,1301,"Cisplatin","1, 2, 3, 4, 5","",28,2,"","X",FALSE,"2","24.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","24.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;"
"92.16.1301.3","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",16,"Cisplatin & Etoposide (EP)",3,1301,"Cisplatin","1,8","",28,2,"","X",FALSE,"2","17.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;","17.cisplatin;0.etoposide;1.etoposide;1.etoposide;1.etoposide;1.etoposide;3.cisplatin;0.etoposide;1.etoposide;1.etoposide;1.etoposide;1.etoposide;"
"92.17.1304.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",17,"Cisplatin & Vinorelbine (CVb)",1,1304,"Cisplatin","2,9","",21,1,"","X",FALSE,"1","0.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;","0.cisplatin;0.vinorelbine;7.cisplatin;0.vinorelbine;"
"92.17.1306.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Consolidation or maintenance after definitive therapy for inoperable disease",17,"Durvalumab monotherapy",1,1306,"Durvalumab","1","",14,3,"","",TRUE,"Cont.","14.Durvalumab;14.Durvalumab;","14.durvalumab;14.durvalumab;"
"92.17.1307.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Consolidation or maintenance after definitive therapy for inoperable disease",17,"Sugemalimab monotherapy",1,1307,"Sugemalimab","1","",21,3,"","",TRUE,"Cont.","21.Sugemalimab;21.Sugemalimab;","21.sugemalimab;21.sugemalimab;"
"92.18.1310.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",18,"Carboplatin & Etoposide (CE)",2,1310,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","26.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;26.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","26.carboplatin;0.etoposide;1.etoposide;1.etoposide;"
"92.21.1314.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",21,"Carboplatin, nab-Paclitaxel, Durvalumab",1,1314,"Carboplatin","1","",21,3,"","",FALSE,"4","7.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.carboplatin;0.durvalumab;0.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"92.22.1314.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",22,"Carboplatin, nab-Paclitaxel, Durvalumab",2,1314,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","14.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.carboplatin;0.durvalumab;0.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"92.23.1314.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",23,"Carboplatin, nab-Paclitaxel, Durvalumab",1,1314,"Carboplatin","1","",21,3,"","",FALSE,"4","7.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tremelimumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tremelimumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.carboplatin;0.durvalumab;0.paclitaxel;0.nanoparticlealbumin-bound;0.tremelimumab;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"92.24.1314.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",24,"Carboplatin, nab-Paclitaxel, Durvalumab",2,1314,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","14.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tremelimumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;14.Carboplatin;0.Durvalumab;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tremelimumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","14.carboplatin;0.durvalumab;0.paclitaxel;0.nanoparticlealbumin-bound;0.tremelimumab;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"92.25.1316.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",25,"Carboplatin & Paclitaxel (CP) & Cemiplimab",1,1316,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Cemiplimab;0.Paclitaxel;21.Carboplatin;0.Cemiplimab;0.Paclitaxel;","21.carboplatin;0.cemiplimab;0.paclitaxel;"
"92.25.1320.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",25,"Cemiplimab monotherapy",1,1320,"Cemiplimab","1","",21,3,"","",TRUE,"Cont.","21.Cemiplimab;21.Cemiplimab;","21.cemiplimab;21.cemiplimab;"
"92.25.1322.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",25,"Cisplatin & Etoposide (EP)",1,1322,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","14.Cisplatin;3.Etoposide;2.Etoposide;2.Etoposide;14.Cisplatin;3.Etoposide;2.Etoposide;2.Etoposide;","14.cisplatin;3.etoposide;2.etoposide;2.etoposide;"
"92.28.1323.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",28,"Cisplatin & Gemcitabine (GC)",1,1323,"Cisplatin","2","",21,3,"","",TRUE,"Cont.","14.Gemcitabine;1.Cisplatin;6.Gemcitabine;14.Gemcitabine;1.Cisplatin;6.Gemcitabine;","14.gemcitabine;1.cisplatin;6.gemcitabine;"
"92.29.1323.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",29,"Cisplatin & Gemcitabine (GC)",2,1323,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.cisplatin;0.gemcitabine;7.gemcitabine;7.gemcitabine;"
"92.3.1283.3","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",3,"Atezolizumab monotherapy",3,1283,"Atezolizumab","1","",28,3,"","",TRUE,"Cont.","28.Atezolizumab;28.Atezolizumab;","28.atezolizumab;28.atezolizumab;"
"92.31.1324.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",31,"Cisplatin & Gemcitabine (GC) & Cetuximab",1,1324,"Cetuximab","1,8,15","",21,3,"","",TRUE,"Cont.","7.Cetuximab;0.Cisplatin;0.Gemcitabine;7.Cetuximab;0.Gemcitabine;7.Cetuximab;7.Cetuximab;0.Cisplatin;0.Gemcitabine;7.Cetuximab;0.Gemcitabine;7.Cetuximab;","7.cetuximab;0.cisplatin;0.gemcitabine;7.cetuximab;0.gemcitabine;7.cetuximab;"
"92.31.1326.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",31,"Cisplatin & Paclitaxel",1,1326,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Paclitaxel;21.Cisplatin;0.Paclitaxel;","21.cisplatin;0.paclitaxel;"
"92.31.1327.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",31,"Cisplatin, Paclitaxel, Cemiplimab",1,1327,"Cemiplimab","1","",21,3,"","",TRUE,"Cont.","21.Cemiplimab;0.Cisplatin;0.Paclitaxel;21.Cemiplimab;0.Cisplatin;0.Paclitaxel;","21.cemiplimab;0.cisplatin;0.paclitaxel;"
"92.31.1328.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",31,"Cisplatin & Vinorelbine (CVb)",1,1328,"Cisplatin","8","",21,3,"","",TRUE,"Cont.","14.Vinorelbine;7.Cisplatin;0.Vinorelbine;14.Vinorelbine;7.Cisplatin;0.Vinorelbine;","14.vinorelbine;7.cisplatin;0.vinorelbine;"
"92.32.1328.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",32,"Cisplatin & Vinorelbine (CVb)",2,1328,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.cisplatin;0.vinorelbine;7.vinorelbine;7.vinorelbine;"
"92.34.1328.4","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",34,"Cisplatin & Vinorelbine (CVb)",4,1328,"Cisplatin","1","",42,3,"","",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.cisplatin;0.vinorelbine;7.vinorelbine;7.vinorelbine;7.vinorelbine;7.vinorelbine;7.vinorelbine;"
"92.35.1329.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",35,"Cisplatin, Vinorelbine, Cetuximab",1,1329,"Cetuximab","1,8,15","",21,3,"","",TRUE,"Cont.","7.Cetuximab;0.Cisplatin;0.Vinorelbine;7.Cetuximab;0.Vinorelbine;7.Cetuximab;7.Cetuximab;0.Cisplatin;0.Vinorelbine;7.Cetuximab;0.Vinorelbine;7.Cetuximab;","7.cetuximab;0.cisplatin;0.vinorelbine;7.cetuximab;0.vinorelbine;7.cetuximab;"
"92.35.1330.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",35,"Docetaxel & Vinorelbine",1,1330,"Docetaxel","1","",14,3,"","",TRUE,"Cont.","14.Docetaxel;0.Vinorelbine;14.Docetaxel;0.Vinorelbine;","14.docetaxel;0.vinorelbine;"
"92.35.1331.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",35,"Durvalumab & Tremelimumab",1,1331,"Durvalumab","1","",28,3,"","",TRUE,"Cont.","28.Durvalumab;0.Tremelimumab;28.Durvalumab;0.Tremelimumab;","28.durvalumab;0.tremelimumab;"
"92.35.1332.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",35,"Gemcitabine & Paclitaxel",1,1332,"Gemcitabine","1,8","",21,3,"","",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;0.Paclitaxel;","14.gemcitabine;0.paclitaxel;7.gemcitabine;0.paclitaxel;"
"92.36.1332.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",36,"Gemcitabine & Paclitaxel",2,1332,"Gemcitabine","1,8","",21,3,"","",TRUE,"Cont.","14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.gemcitabine;0.paclitaxel;7.gemcitabine;"
"92.37.1333.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",37,"Gemcitabine & Vinorelbine",1,1333,"Gemcitabine","1,8","",21,3,"","",TRUE,"Cont.","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","14.gemcitabine;0.vinorelbine;7.gemcitabine;0.vinorelbine;"
"92.38.1333.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",38,"Gemcitabine & Vinorelbine",2,1333,"Gemcitabine","1,8,15","",28,3,"","",TRUE,"Cont.","14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;14.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;7.Gemcitabine;0.Vinorelbine;","14.gemcitabine;0.vinorelbine;7.gemcitabine;0.vinorelbine;7.gemcitabine;0.vinorelbine;"
"92.39.1334.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",39,"Ipilimumab & Nivolumab",1,1334,"Ipilimumab","1","",42,3,"","",TRUE,"Cont.","14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;14.Ipilimumab;0.Nivolumab;14.Nivolumab;14.Nivolumab;","14.ipilimumab;0.nivolumab;14.nivolumab;14.nivolumab;"
"92.39.1336.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",39,"PCG (Carboplatin)",1,1336,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;0.Paclitaxel;7.Gemcitabine;","14.carboplatin;0.gemcitabine;0.paclitaxel;7.gemcitabine;"
"92.4.1289.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vinblastine",1,1289,"Cisplatin","1,22,43,64","",84,1,"","",FALSE,"1","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;7.Vinblastine;14.Cisplatin;0.Vinblastine;14.Vinblastine;7.Cisplatin;","0.cisplatin;0.vinblastine;7.vinblastine;7.vinblastine;7.cisplatin;0.vinblastine;7.vinblastine;14.cisplatin;0.vinblastine;14.vinblastine;7.cisplatin;"
"92.4.1290.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vindesine",1,1290,"Cisplatin","1,22,43,64","",84,1,"","",FALSE,"1","0.Cisplatin;0.Vindesine;7.Vindesine;7.Vindesine;7.Cisplatin;0.Vindesine;7.Vindesine;14.Cisplatin;0.Vindesine;14.Vindesine;7.Cisplatin;","0.cisplatin;0.vindesine;7.vindesine;7.vindesine;7.cisplatin;0.vindesine;7.vindesine;14.cisplatin;0.vindesine;14.vindesine;7.cisplatin;"
"92.4.1291.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Vinorelbine (CVb)",1,1291,"Cisplatin","1,8","",28,3,"","",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.cisplatin;0.vinorelbine;7.cisplatin;0.vinorelbine;7.vinorelbine;7.vinorelbine;"
"92.42.1342.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",42,"Docetaxel monotherapy",2,1342,"Docetaxel","1,8","",21,3,"","",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;","14.docetaxel;7.docetaxel;"
"92.46.1346.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",46,"Vinorelbine monotherapy",1,1346,"Vinorelbine","1,8","",21,3,"","",TRUE,"Cont.","14.Vinorelbine;7.Vinorelbine;14.Vinorelbine;7.Vinorelbine;","14.vinorelbine;7.vinorelbine;"
"92.48.1355.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",48,"Docetaxel monotherapy",1,1355,"Docetaxel","1,15","",28,3,"","",TRUE,"Cont.","14.Docetaxel;14.Docetaxel;14.Docetaxel;14.Docetaxel;","14.docetaxel;14.docetaxel;"
"92.48.1356.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",48,"Docetaxel & Ramucirumab",1,1356,"Docetaxel","1","",21,3,"","",TRUE,"Cont.","21.Docetaxel;0.Ramucirumab;21.Docetaxel;0.Ramucirumab;","21.docetaxel;0.ramucirumab;"
"92.48.1357.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",48,"Docetaxel & V&etanib",1,1357,"Docetaxel","1","",21,3,"","",TRUE,"Cont.","1.Docetaxel;0.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Docetaxel;0.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;1.Vandetanib;","1.docetaxel;0.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;1.vandetanib;"
"92.48.1365.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",48,"Afatinib & Paclitaxel",1,1365,"Afatinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Paclitaxel;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.afatinib;0.paclitaxel;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;"
"92.49.1368.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",49,"Docetaxel monotherapy",2,1368,"Docetaxel","1,8,15","",21,3,"","",TRUE,"Cont.","7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;7.Docetaxel;","7.docetaxel;7.docetaxel;"
"92.51.1369.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",51,"Docetaxel & Nintedanib",1,1369,"Docetaxel","1","",21,3,"","",TRUE,"Cont.","1.Docetaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Docetaxel;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;","1.docetaxel;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;"
"92.51.1370.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",51,"Docetaxel & Nivolumab",1,1370,"Docetaxel","1","",28,3,"","",TRUE,"Cont.","28.Docetaxel;0.Nivolumab;28.Docetaxel;0.Nivolumab;","28.docetaxel;0.nivolumab;"
"92.53.1374.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",53,"nab-Paclitaxel monotherapy",1,1374,"Paclitaxel, nanoparticle albumin-bound","1,8,15","",21,3,"","",TRUE,"Cont.","7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.paclitaxel;0.nanoparticlealbumin-bound;"
"92.53.1375.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",53,"S-1 monotherapy",1,1375,"Tegafur, gimeracil, oteracil","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",42,3,"","",TRUE,"Cont.","15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;15.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","15.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;"
"92.53.1376.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, subsequent lines of therapy",53,"Tislelizumab monotherapy",1,1376,"Tislelizumab","1","",21,3,"","",TRUE,"Cont.","21.Tislelizumab;21.Tislelizumab;","21.tislelizumab;21.tislelizumab;"
"92.7.1296.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",7,"Carboplatin & Paclitaxel (CP)",1,1296,"Carboplatin","1,8,15,22,29,36","",42,1,"","X",FALSE,"1","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","0.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;"
"92.8.1296.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",8,"Carboplatin & Paclitaxel (CP)",2,1296,"Carboplatin","1,8,15","",21,2,"","X",FALSE,"2","7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","7.carboplatin;0.paclitaxel;"
"92.9.1296.3","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",9,"Carboplatin & Paclitaxel (CP)",3,1296,"Carboplatin","1,8,15,22,29,36,43","",49,1,"","X",FALSE,"1","0.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;7.Carboplatin;0.Paclitaxel;","0.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;7.carboplatin;0.paclitaxel;"
"93.53.1379.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Neoadjuvant therapy",53,"Cisplatin, Pemetrexed, Nivolumab",1,1379,"Cisplatin","1","",21,3,"","",FALSE,"3","21.Cisplatin;0.Nivolumab;0.Pemetrexed;21.Cisplatin;0.Nivolumab;0.Pemetrexed;","21.cisplatin;0.nivolumab;0.pemetrexed;"
"93.53.1383.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Definitive therapy for locally advanced disease",53,"Cisplatin & Etoposide (EP)",1,1383,"Cisplatin","1,8","",42,3,"","X",TRUE,"Cont.","35.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;35.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;","35.cisplatin;0.etoposide;1.etoposide;1.etoposide;1.etoposide;1.etoposide;3.cisplatin;"
"93.53.1387.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"ABCP",1,1387,"Atezolizumab","1","",21,3,"","",TRUE,"Cont.","21.Atezolizumab;0.Bevacizumab;0.Carboplatin;0.Paclitaxel;21.Atezolizumab;0.Bevacizumab;0.Carboplatin;0.Paclitaxel;","21.atezolizumab;0.bevacizumab;0.carboplatin;0.paclitaxel;"
"93.53.1390.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin & Gemcitabine (GCb)",1,1390,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","28.Carboplatin;0.Gemcitabine;28.Carboplatin;0.Gemcitabine;","28.carboplatin;0.gemcitabine;"
"93.53.1394.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin & Paclitaxel (CP), Bevacizumab, Nivolumab",1,1394,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Nivolumab;0.Paclitaxel;21.Bevacizumab;0.Carboplatin;0.Nivolumab;0.Paclitaxel;","21.bevacizumab;0.carboplatin;0.nivolumab;0.paclitaxel;"
"93.53.1396.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Atezolizumab",1,1396,"Atezolizumab","1","",21,3,"","",TRUE,"Cont.","21.Atezolizumab;0.Carboplatin;0.Pemetrexed;21.Atezolizumab;0.Carboplatin;0.Pemetrexed;","21.atezolizumab;0.carboplatin;0.pemetrexed;"
"93.53.1398.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Cemiplimab",1,1398,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Cemiplimab;0.Pemetrexed;21.Carboplatin;0.Cemiplimab;0.Pemetrexed;","21.carboplatin;0.cemiplimab;0.pemetrexed;"
"93.53.1399.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Ipilimumab, Nivolumab",1,1399,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;","21.carboplatin;0.ipilimumab;0.nivolumab;0.pemetrexed;"
"93.53.1400.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Pembrolizumab",1,1400,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Pembrolizumab;0.Pemetrexed;21.Carboplatin;0.Pembrolizumab;0.Pemetrexed;","21.carboplatin;0.pembrolizumab;0.pemetrexed;"
"93.53.1401.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Sintilimab",1,1401,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;0.Sintilimab;21.Carboplatin;0.Pemetrexed;0.Sintilimab;","21.carboplatin;0.pemetrexed;0.sintilimab;"
"93.53.1402.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Sugemalimab",1,1402,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;0.Sugemalimab;21.Carboplatin;0.Pemetrexed;0.Sugemalimab;","21.carboplatin;0.pemetrexed;0.sugemalimab;"
"93.53.1403.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, Pemetrexed, Tislelizumab",1,1403,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;0.Tislelizumab;21.Carboplatin;0.Pemetrexed;0.Tislelizumab;","21.carboplatin;0.pemetrexed;0.tislelizumab;"
"93.53.1406.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin & Gemcitabine (GC) & Bevacizumab",1,1406,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Bevacizumab;0.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.bevacizumab;0.cisplatin;0.gemcitabine;7.gemcitabine;"
"93.53.1408.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Atezolizumab",1,1408,"Atezolizumab","1","",21,3,"","",TRUE,"Cont.","21.Atezolizumab;0.Cisplatin;0.Pemetrexed;21.Atezolizumab;0.Cisplatin;0.Pemetrexed;","21.atezolizumab;0.cisplatin;0.pemetrexed;"
"93.53.1409.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Bevacizumab",1,1409,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;0.Cisplatin;0.Pemetrexed;21.Bevacizumab;0.Cisplatin;0.Pemetrexed;","21.bevacizumab;0.cisplatin;0.pemetrexed;"
"93.53.1410.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Cemiplimab",1,1410,"Cemiplimab","1","",21,3,"","",TRUE,"Cont.","21.Cemiplimab;0.Cisplatin;0.Pemetrexed;21.Cemiplimab;0.Cisplatin;0.Pemetrexed;","21.cemiplimab;0.cisplatin;0.pemetrexed;"
"93.53.1411.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Ipilimumab, Nivolumab",1,1411,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;21.Cisplatin;0.Ipilimumab;0.Nivolumab;0.Pemetrexed;","21.cisplatin;0.ipilimumab;0.nivolumab;0.pemetrexed;"
"93.53.1412.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Pembrolizumab",1,1412,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Pembrolizumab;0.Pemetrexed;21.Cisplatin;0.Pembrolizumab;0.Pemetrexed;","21.cisplatin;0.pembrolizumab;0.pemetrexed;"
"93.53.1413.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Sintilimab",1,1413,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;0.Sintilimab;21.Cisplatin;0.Pemetrexed;0.Sintilimab;","21.cisplatin;0.pemetrexed;0.sintilimab;"
"93.53.1414.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Cisplatin, Pemetrexed, Tislelizumab",1,1414,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;0.Tislelizumab;21.Cisplatin;0.Pemetrexed;0.Tislelizumab;","21.cisplatin;0.pemetrexed;0.tislelizumab;"
"93.53.1420.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, subsequent lines of therapy",53,"Gefitinib monotherapy",1,1420,"Gefitinib","1","",21,3,"","",TRUE,"Cont.","21.Gefitinib;21.Gefitinib;","21.gefitinib;21.gefitinib;"
"93.53.1421.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, subsequent lines of therapy",53,"Nintedanib & Pemetrexed",1,1421,"Nintedanib","2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",21,3,"","",TRUE,"Cont.","1.Pemetrexed;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Pemetrexed;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;1.Nintedanib;","1.pemetrexed;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;1.nintedanib;"
"93.53.1424.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, subsequent lines of therapy",53,"Sorafenib monotherapy",1,1424,"Sorafenib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;1.Sorafenib;","1.sorafenib;1.sorafenib;"
"94.53.1426.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Neoadjuvant therapy",53,"Cisplatin & Gemcitabine (GC) & Nivolumab",1,1426,"Cisplatin","1","",21,3,"","",FALSE,"3","14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;0.Nivolumab;7.Gemcitabine;","14.cisplatin;0.gemcitabine;0.nivolumab;7.gemcitabine;"
"94.53.1432.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",53,"Carboplatin, nab-Paclitaxel, Pembrolizumab",1,1432,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Pembrolizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.carboplatin;0.paclitaxel;0.nanoparticlealbumin-bound;0.pembrolizumab;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"94.53.1433.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",53,"Carboplatin & nab-Paclitaxel (CnP) & Tislelizumab",1,1433,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tislelizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;0.Tislelizumab;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.carboplatin;0.paclitaxel;0.nanoparticlealbumin-bound;0.tislelizumab;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"94.53.1435.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",53,"Carboplatin & Paclitaxel (CP) & Camrelizumab",1,1435,"Camrelizumab","1","",21,3,"","",TRUE,"Cont.","21.Camrelizumab;0.Carboplatin;0.Paclitaxel;21.Camrelizumab;0.Carboplatin;0.Paclitaxel;","21.camrelizumab;0.carboplatin;0.paclitaxel;"
"94.54.1436.2","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",54,"Carboplatin & Paclitaxel (CP) & Ipilimumab",2,1436,"Carboplatin","1","",84,3,"","",TRUE,"Cont.","84.Carboplatin;0.Ipilimumab;0.Paclitaxel;84.Carboplatin;0.Ipilimumab;0.Paclitaxel;","84.carboplatin;0.ipilimumab;0.paclitaxel;"
"94.55.1437.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",55,"Carboplatin & Paclitaxel (CP) & Ipilimumab, Nivolumab",1,1437,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Paclitaxel;21.Carboplatin;0.Ipilimumab;0.Nivolumab;0.Paclitaxel;","21.carboplatin;0.ipilimumab;0.nivolumab;0.paclitaxel;"
"94.55.1438.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",55,"Carboplatin & Paclitaxel (CP) & Pembrolizumab",1,1438,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;21.Carboplatin;0.Paclitaxel;0.Pembrolizumab;","21.carboplatin;0.paclitaxel;0.pembrolizumab;"
"94.55.1439.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",55,"Carboplatin & Paclitaxel (CP) & Sugemalimab",1,1439,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Sugemalimab;21.Carboplatin;0.Paclitaxel;0.Sugemalimab;","21.carboplatin;0.paclitaxel;0.sugemalimab;"
"94.55.1440.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",55,"Carboplatin & Paclitaxel (CP) & Tislelizumab",1,1440,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;0.Tislelizumab;21.Carboplatin;0.Paclitaxel;0.Tislelizumab;","21.carboplatin;0.paclitaxel;0.tislelizumab;"
"94.55.1443.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",55,"Cisplatin & Gemcitabine (GC) & Necitumumab",1,1443,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;0.Necitumumab;7.Gemcitabine;0.Necitumumab;14.Cisplatin;0.Gemcitabine;0.Necitumumab;7.Gemcitabine;0.Necitumumab;","14.cisplatin;0.gemcitabine;0.necitumumab;7.gemcitabine;0.necitumumab;"
"94.55.1445.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",55,"Docetaxel & Nedaplatin",1,1445,"Docetaxel","1","",21,3,"","",TRUE,"Cont.","21.Docetaxel;0.Nedaplatin;21.Docetaxel;0.Nedaplatin;","21.docetaxel;0.nedaplatin;"
"94.55.1446.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Maintenance after first-line therapy",55,"S-1 monotherapy",1,1446,"Tegafur, gimeracil, oteracil","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14","",21,3,"","",TRUE,"Cont.","8.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;8.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;1.Tegafur;0.gimeracil;0.oteracil;","8.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;1.tegafur;0.gimeracil;0.oteracil;"
"94.55.1449.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, second-line",55,"Sintilimab monotherapy",1,1449,"Sintilimab","1","",21,3,"","",TRUE,"Cont.","21.Sintilimab;21.Sintilimab;","21.sintilimab;21.sintilimab;"
"96.55.1467.1","Thoraic Oncology","Non-small cell lung cancer, BRAF-mutated",96,"Advanced or metastatic disease, first-line",55,"Dabrafenib & Trametinib",1,1467,"Dabrafenib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;1.Dabrafenib;0.Dabrafenib;0.Trametinib;0.Trametinib;","1.dabrafenib;0.dabrafenib;0.trametinib;0.trametinib;"
"97.55.1474.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, platinum-exposed",55,"Amivantamab monotherapy",1,1474,"Amivantamab","1","",7,3,"","",TRUE,"Cont.","7.Amivantamab;7.Amivantamab;","7.amivantamab;7.amivantamab;"
"97.56.1474.2","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, platinum-exposed",56,"Amivantamab monotherapy",2,1474,"Amivantamab","1","",14,3,"","",TRUE,"Cont.","14.Amivantamab;14.Amivantamab;","14.amivantamab;14.amivantamab;"
"97.57.1475.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, platinum-exposed",57,"Mobocertinib monotherapy",1,1475,"Mobocertinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;1.Mobocertinib;","1.mobocertinib;1.mobocertinib;"
"97.57.1477.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",57,"Apatinib & Gefitinib",1,1477,"Apatinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;1.Apatinib;0.Gefitinib;","1.apatinib;0.gefitinib;"
"97.57.1478.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",57,"Aumolertinib monotherapy",1,1478,"Aumolertinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;1.Aumolertinib;","1.aumolertinib;1.aumolertinib;"
"97.57.1480.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",57,"Carboplatin & Gemcitabine (GCb)",1,1480,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","21.Carboplatin;0.Gemcitabine;7.Gemcitabine;21.Carboplatin;0.Gemcitabine;7.Gemcitabine;","21.carboplatin;0.gemcitabine;7.gemcitabine;"
"97.57.1481.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",57,"Carboplatin & Gemcitabine/Erlotinib",1,1481,"Carboplatin","1","",28,3,"","",FALSE,"4","1.Carboplatin;0.Carboplatin;0.Gemcitabine;0.Gemcitabine;7.Gemcitabine;0.Gemcitabine;7.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Carboplatin;0.Carboplatin;0.Gemcitabine;0.Gemcitabine;7.Gemcitabine;0.Gemcitabine;7.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;1.Erlotinib;0.Erlotinib;","1.carboplatin;0.carboplatin;0.gemcitabine;0.gemcitabine;7.gemcitabine;0.gemcitabine;7.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;1.erlotinib;0.erlotinib;"
"97.59.1485.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Cisplatin & Gemcitabine/Erlotinib",1,1485,"Cisplatin","1","",28,3,"","",FALSE,"4","1.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Cisplatin;0.Gemcitabine;7.Gemcitabine;7.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.cisplatin;0.gemcitabine;7.gemcitabine;7.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;"
"97.59.1488.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Dacomitinib monotherapy",1,1488,"Dacomitinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;1.Dacomitinib;","1.dacomitinib;1.dacomitinib;"
"97.59.1489.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Erlotinib monotherapy",1,1489,"Erlotinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",21,3,"","",TRUE,"Cont.","1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.erlotinib;1.erlotinib;"
"97.59.1490.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Erlotinib & Bevacizumab",1,1490,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Bevacizumab;0.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.bevacizumab;0.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;"
"97.59.1491.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Erlotinib & Ramucirumab",1,1491,"Erlotinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14","",14,3,"","",TRUE,"Cont.","1.Erlotinib;0.Ramucirumab;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;0.Ramucirumab;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;1.Erlotinib;","1.erlotinib;0.ramucirumab;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;1.erlotinib;"
"97.59.1492.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Furmonertinib monotherapy",1,1492,"Furmonertinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",21,3,"","",TRUE,"Cont.","1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;1.Furmonertinib;","1.furmonertinib;1.furmonertinib;"
"97.59.1493.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"GCP",1,1493,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","1.Carboplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Carboplatin;0.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.carboplatin;0.gefitinib;0.pemetrexed;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;"
"97.59.1495.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Gefitinib & Pemetrexed",1,1495,"Gefitinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",21,3,"","",TRUE,"Cont.","1.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;0.Pemetrexed;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.gefitinib;0.pemetrexed;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;1.gefitinib;"
"97.59.1499.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-exposed",59,"Afatinib & Bevacizumab",1,1499,"Afatinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21","",21,3,"","",TRUE,"Cont.","1.Afatinib;0.Bevacizumab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Bevacizumab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.afatinib;0.bevacizumab;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;"
"97.59.1500.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-exposed",59,"Afatinib & Cetuximab",1,1500,"Afatinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14","",14,3,"","",TRUE,"Cont.","1.Afatinib;0.Cetuximab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;0.Cetuximab;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.afatinib;0.cetuximab;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;1.afatinib;"
"97.59.1504.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR p.T790M mutation",59,"Docetaxel & Bevacizumab",1,1504,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;0.Docetaxel;21.Bevacizumab;0.Docetaxel;","21.bevacizumab;0.docetaxel;"
"98.59.1506.1","Thoraic Oncology","Non-small cell lung cancer, HER2-mutated",98,"Metastatic disease, all lines of therapy",59,"Trastuzumab deruxtecan monotherapy",1,1506,"Trastuzumab deruxtecan","1","",21,3,"","",TRUE,"Cont.","21.Trastuzumabderuxtecan;21.Trastuzumabderuxtecan;","21.trastuzumabderuxtecan;21.trastuzumabderuxtecan;"
"99.59.1507.1","Thoraic Oncology","Non-small cell lung cancer, KRAS-mutated",99,"Advanced or metastatic disease, subsequent lines of therapy",59,"Adagrasib monotherapy",1,1507,"Adagrasib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;1.Adagrasib;","1.adagrasib;1.adagrasib;"
"99.59.1509.1","Thoraic Oncology","Non-small cell lung cancer, KRAS-mutated",99,"Advanced or metastatic disease, subsequent lines of therapy",59,"Sotorasib monotherapy",1,1509,"Sotorasib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;1.Sotorasib;","1.sotorasib;1.sotorasib;"
"102.59.1522.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"EGFR-mutated, all lines of therapy",59,"Afatinib monotherapy",1,1522,"Afatinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;1.Afatinib;","1.afatinib;1.afatinib;"
"102.59.1520.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"ALK-mutated, all lines of therapy",59,"Alectinib monotherapy",1,1520,"Alectinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;1.Alectinib;","1.alectinib;1.alectinib;"
"95.55.1453.1","Thoraic Oncology","Non-small cell lung cancer, ALK-positive",95,"Advanced or metastatic disease, ALK inhibitor-naive",55,"Brigatinib monotherapy",1,1453,"Brigatinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;1.Brigatinib;","1.brigatinib;1.brigatinib;"
"92.48.1354.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",48,"Cabozantinib & Erlotinib",1,1354,"Cabozantinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;1.Cabozantinib;0.Erlotinib;","1.cabozantinib;0.erlotinib;"
"92.48.1353.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, second-line",48,"Cabozantinib monotherapy",1,1353,"Cabozantinib","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;1.Cabozantinib;","1.cabozantinib;1.cabozantinib;"
"1011.59.1514.1","Thoraic Oncology","Non-small cell lung cancer, ROS1-positive",1011,"Advanced or metastatic disease, ROS1 inhibitor-naive",59,"Ceritinib monotherapy",1,1514,"Ceritinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;1.Ceritinib;","1.ceritinib;1.ceritinib;"
"1011.59.1515.1","Thoraic Oncology","Non-small cell lung cancer, ROS1-positive",1011,"Advanced or metastatic disease, ROS1 inhibitor-naive",59,"Crizotinib monotherapy",1,1515,"Crizotinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;1.Crizotinib;","1.crizotinib;1.crizotinib;"
"102.59.1524.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"EGFR-mutated, all lines of therapy",59,"Gefitinib monotherapy",1,1524,"Gefitinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;1.Gefitinib;","1.gefitinib;1.gefitinib;"
"102.59.1526.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"EGFR-mutated, all lines of therapy",59,"Icotinib monotherapy",1,1526,"Icotinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;1.Icotinib;","1.icotinib;1.icotinib;"
"1011.59.1517.1","Thoraic Oncology","Non-small cell lung cancer, ROS1-positive",1011,"Advanced or metastatic disease, ROS1 inhibitor-exosed",59,"Lorlatinib monotherapy",1,1517,"Lorlatinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;1.Lorlatinib;","1.lorlatinib;1.lorlatinib;"
"102.59.1527.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"EGFR-mutated, all lines of therapy",59,"Osimertinib monotherapy",1,1527,"Osimertinib","1, 2, 3, 4, 5, 6, 7","",7,3,"","",TRUE,"Cont.","1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;1.Osimertinib;","1.osimertinib;1.osimertinib;"
"92.7.1293.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",7,"Tegafur & uracil monotherapy",1,1293,"Tegafur and uracil","1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28","",28,3,"","",TRUE,"Cont.","1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;1.Tegafuranduracil;","1.tegafuranduracil;1.tegafuranduracil;"
"92.19.1311.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",19,"Carboplatin & Gemcitabine (GCb)",1,1311,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;","14.carboplatin;0.gemcitabine;7.gemcitabine;"
"92.1.1280.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Gemcitabine (GC)",1,1280,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","14.Cisplatin;0.Gemcitabine;7.Gemcitabine;14.Cisplatin;0.Gemcitabine;7.Gemcitabine;","14.cisplatin;0.gemcitabine;7.gemcitabine;"
"103.63.1533.1","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, consolidation after upfront therapy",63,"Cisplatin & Irinotecan (IC)",1,1533,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","14.Cisplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;14.Cisplatin;0.Irinotecan;7.Irinotecan;7.Irinotecan;","14.cisplatin;0.irinotecan;7.irinotecan;7.irinotecan;"
"92.1.1281.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Vinorelbine (CVb)",1,1281,"Cisplatin","1","",21,3,"","",FALSE,"3","14.Cisplatin;0.Vinorelbine;7.Vinorelbine;14.Cisplatin;0.Vinorelbine;7.Vinorelbine;","14.cisplatin;0.vinorelbine;7.vinorelbine;"
"92.41.1342.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",41,"Docetaxel monotherapy",1,1342,"Docetaxel","1,8,15","",28,3,"","",TRUE,"Cont.","14.Docetaxel;7.Docetaxel;7.Docetaxel;14.Docetaxel;7.Docetaxel;7.Docetaxel;","14.docetaxel;7.docetaxel;7.docetaxel;"
"92.45.1343.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",45,"Gemcitabine monotherapy",2,1343,"Gemcitabine","1,8","",21,3,"","",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;","14.gemcitabine;7.gemcitabine;"
"92.39.1335.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",39,"Nivolumab monotherapy",1,1335,"Nivolumab","1","",14,3,"","",TRUE,"Cont.","14.Nivolumab;14.Nivolumab;","14.nivolumab;14.nivolumab;"
"103.78.1547.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",78,"Ifosfamide monotherapy",1,1547,"Ifosfamide","1,2,3,4,5","",21,3,"","",TRUE,"Cont.","17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;17.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;1.Ifosfamide;","17.ifosfamide;1.ifosfamide;1.ifosfamide;1.ifosfamide;1.ifosfamide;"
"103.78.1553.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, second-line",78,"Amrubicin monotherapy",1,1553,"Amrubicin","1,2,3","",21,3,"","",TRUE,"Cont.","19.Amrubicin;1.Amrubicin;1.Amrubicin;19.Amrubicin;1.Amrubicin;1.Amrubicin;","19.amrubicin;1.amrubicin;1.amrubicin;"
"104.84.1571.1","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",84,"PAC",1,1571,"Cisplatin","1,2,3","",21,3,"","",FALSE,"3","19.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;19.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;","19.cisplatin;0.cyclophosphamide;0.doxorubicin;1.cisplatin;1.cisplatin;"
"103.59.1529.1","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, induction",59,"Cisplatin & Etoposide (EP)",1,1529,"Cisplatin","1,2,3","",21,3,"","",TRUE,"Cont.","19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;19.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","19.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;"
"103.61.1531.1","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, definitive chemoradiotherapy",61,"Cisplatin & Etoposide (EP)",1,1531,"Cisplatin","1","",21,3,"","X",TRUE,"Cont.","19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.cisplatin;0.etoposide;1.etoposide;1.etoposide;"
"92.17.1308.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",17,"Atezolizumab monotherapy",1,1308,"Atezolizumab","1","",21,3,"","",TRUE,"Cont.","21.Atezolizumab;21.Atezolizumab;","21.atezolizumab;21.atezolizumab;"
"92.25.1315.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",25,"Carboplatin & Paclitaxel (CP) & Bevacizumab",1,1315,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Paclitaxel;21.Bevacizumab;0.Carboplatin;0.Paclitaxel;","21.bevacizumab;0.carboplatin;0.paclitaxel;"
"92.41.1341.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",41,"Carboplatin, Pemetrexed, Bevacizumab",1,1341,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;0.Carboplatin;0.Pemetrexed;21.Bevacizumab;0.Carboplatin;0.Pemetrexed;","21.bevacizumab;0.carboplatin;0.pemetrexed;"
"92.46.1345.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",46,"Pemetrexed & Bevacizumab",1,1345,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;0.Pemetrexed;21.Bevacizumab;0.Pemetrexed;","21.bevacizumab;0.pemetrexed;"
"103.78.1550.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, maintenance after first-line therapy",78,"Bevacizumab monotherapy",1,1550,"Bevacizumab","1","",21,3,"","",TRUE,"Cont.","21.Bevacizumab;21.Bevacizumab;","21.bevacizumab;21.bevacizumab;"
"92.17.1309.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",17,"Carboplatin & Docetaxel",1,1309,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Docetaxel;21.Carboplatin;0.Docetaxel;","21.carboplatin;0.docetaxel;"
"103.69.1541.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",69,"Carboplatin & Paclitaxel (CP) & Ipilimumab",1,1541,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Ipilimumab;0.Paclitaxel;21.Carboplatin;0.Ipilimumab;0.Paclitaxel;","21.carboplatin;0.ipilimumab;0.paclitaxel;"
"92.25.1318.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",25,"Carboplatin & Pemetrexed",1,1318,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Pemetrexed;21.Carboplatin;0.Pemetrexed;","21.carboplatin;0.pemetrexed;"
"92.1.1276.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Docetaxel (DC)",1,1276,"Cisplatin","1","",21,3,"","",FALSE,"3","21.Cisplatin;0.Docetaxel;21.Cisplatin;0.Docetaxel;","21.cisplatin;0.docetaxel;"
"92.39.1337.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",39,"Pembrolizumab monotherapy",1,1337,"Pembrolizumab","1","",21,3,"","",TRUE,"Cont.","21.Pembrolizumab;21.Pembrolizumab;","21.pembrolizumab;21.pembrolizumab;"
"92.46.1344.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",46,"Pemetrexed monotherapy",1,1344,"Pemetrexed","1","",21,3,"","",TRUE,"Cont.","21.Pemetrexed;21.Pemetrexed;","21.pemetrexed;21.pemetrexed;"
"93.53.1391.1","Thoraic Oncology","Non-small cell lung cancer, nonsquamous",93,"Advanced or metastatic disease, first-line",53,"Carboplatin, nab-Paclitaxel, Atezolizumab",1,1391,"Atezolizumab","1","",21,3,"","",TRUE,"Cont.","7.Atezolizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Atezolizumab;0.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.atezolizumab;0.carboplatin;0.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"92.21.1313.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",21,"Carboplatin & nab-Paclitaxel",1,1313,"Carboplatin","1","",21,3,"","",FALSE,"6","7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Carboplatin;0.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;7.Paclitaxel;0.nanoparticlealbumin-bound;","7.carboplatin;0.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;7.paclitaxel;0.nanoparticlealbumin-bound;"
"103.84.1570.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",84,"Vinorelbine monotherapy",1,1570,"Vinorelbine","1,8,15","",21,3,"","",TRUE,"Cont.","7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.vinorelbine;7.vinorelbine;"
"103.78.1551.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, maintenance after first-line therapy",78,"Ipilimumab monotherapy",1,1551,"Ipilimumab","1","",84,3,"","",TRUE,"Cont.","84.Ipilimumab;84.Ipilimumab;","84.ipilimumab;84.ipilimumab;"
"92.7.1295.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Induction chemotherapy for locally advanced disease",7,"Cisplatin & Vinblastine",1,1295,"Cisplatin","1,29","",35,1,"","",FALSE,"1","0.Cisplatin;0.Vinblastine;7.Vinblastine;7.Vinblastine;7.Vinblastine;7.Cisplatin;0.Vinblastine;","0.cisplatin;0.vinblastine;7.vinblastine;7.vinblastine;7.vinblastine;7.cisplatin;0.vinblastine;"
"92.25.1319.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",25,"Carboplatin & Vinorelbine",1,1319,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","14.Carboplatin;0.Vinorelbine;7.Vinorelbine;14.Carboplatin;0.Vinorelbine;7.Vinorelbine;","14.carboplatin;0.vinorelbine;7.vinorelbine;"
"103.59.1528.1","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, induction",59,"Carboplatin & Etoposide (CE)",1,1528,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;19.Carboplatin;0.Etoposide;1.Etoposide;1.Etoposide;","19.carboplatin;0.etoposide;1.etoposide;1.etoposide;"
"94.53.1434.1","Thoraic Oncology","Non-small cell lung cancer, squamous",94,"Advanced or metastatic disease, first-line",53,"Carboplatin & Paclitaxel (CP)",1,1434,"Carboplatin","1","",21,3,"","",TRUE,"Cont.","21.Carboplatin;0.Paclitaxel;21.Carboplatin;0.Paclitaxel;","21.carboplatin;0.paclitaxel;"
"92.4.1288.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Adjuvant therapy",4,"Cisplatin & Pemetrexed",1,1288,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Pemetrexed;21.Cisplatin;0.Pemetrexed;","21.cisplatin;0.pemetrexed;"
"97.59.1486.1","Thoraic Oncology","Non-small cell lung cancer, EGFR-mutated",97,"Advanced or metastatic disease, EGFR inhibitor-naive",59,"Cisplatin Monotherapy",1,1486,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;21.Cisplatin;","21.cisplatin;21.cisplatin;"
"92.10.1299.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",10,"Cisplatin Monotherapy",1,1299,"Cisplatin","1,2,4,5,6","",7,2,"","X",FALSE,"2","2.Cisplatin;1.Cisplatin;2.Cisplatin;1.Cisplatin;1.Cisplatin;","2.cisplatin;1.cisplatin;2.cisplatin;1.cisplatin;1.cisplatin;"
"92.14.1301.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Definitive therapy for locally advanced disease",14,"Cisplatin & Etoposide (EP)",1,1301,"Cisplatin","1,8","",28,2,"","X",FALSE,"2","21.Cisplatin;0.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;1.Etoposide;3.Cisplatin;","21.cisplatin;0.etoposide;1.etoposide;1.etoposide;1.etoposide;1.etoposide;3.cisplatin;"
"102.59.1518.1","Thoraic Oncology","Non-small cell lung cancer, CNS metastases",102,"All lines of therapy",59,"Cisplatin & Vinorelbine (CVb)",1,1518,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Cisplatin;0.Vinorelbine;7.Vinorelbine;7.Vinorelbine;7.Vinorelbine;","7.cisplatin;0.vinorelbine;7.vinorelbine;7.vinorelbine;7.vinorelbine;"
"103.60.1529.2","Thoraic Oncology","Small cell lung cancer",103,"Limited stage, induction",60,"Cisplatin & Etoposide (EP)",2,1529,"Cisplatin","1,2,3","",28,3,"","",TRUE,"Cont.","26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;26.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;1.Cisplatin;0.Etoposide;","26.cisplatin;0.etoposide;1.cisplatin;0.etoposide;1.cisplatin;0.etoposide;"
"103.78.1546.1","Thoraic Oncology","Small cell lung cancer",103,"Extensive stage, induction",78,"Docetaxel monotherapy",1,1546,"Docetaxel","1","",21,3,"","",TRUE,"Cont.","21.Docetaxel;21.Docetaxel;","21.docetaxel;21.docetaxel;"
"103.78.1563.1","Thoraic Oncology","Small cell lung cancer",103,"Relapsed or refractory disease, subsequent lines",78,"Gemcitabine monotherapy",1,1563,"Gemcitabine","1,8,15","",28,3,"","",TRUE,"Cont.","14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.gemcitabine;7.gemcitabine;7.gemcitabine;"
"104.85.1571.2","Thoraic Oncology","Thymoma",104,"Neoadjuvant therapy for borderline resectable disease",85,"PAC",2,1571,"Cisplatin","1,2,3","",28,3,"","",FALSE,"3","26.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;26.Cisplatin;0.Cyclophosphamide;0.Doxorubicin;1.Cisplatin;1.Cisplatin;","26.cisplatin;0.cyclophosphamide;0.doxorubicin;1.cisplatin;1.cisplatin;"
"92.1.1279.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Neoadjuvant therapy",1,"Cisplatin & Etoposide (EP)",1,1279,"Cisplatin","1","",21,3,"","",TRUE,"Cont.","21.Cisplatin;0.Etoposide;21.Cisplatin;0.Etoposide;","21.cisplatin;0.etoposide;"
"92.20.1311.2","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",20,"Carboplatin & Gemcitabine (GCb)",2,1311,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","14.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;14.Carboplatin;0.Gemcitabine;7.Gemcitabine;7.Gemcitabine;","14.carboplatin;0.gemcitabine;7.gemcitabine;7.gemcitabine;"
"92.30.1323.3","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line",30,"Cisplatin & Gemcitabine (GC)",3,1323,"Cisplatin","1","",28,3,"","",TRUE,"Cont.","21.Cisplatin;0.Gemcitabine;7.Gemcitabine;21.Cisplatin;0.Gemcitabine;7.Gemcitabine;","21.cisplatin;0.gemcitabine;7.gemcitabine;"
"92.41.1339.1","Thoraic Oncology","Non-small cell lung cancer (NSCLC)",92,"Advanced or metastatic disease, first-line, elderly or poor performance status",41,"Carboplatin & Paclitaxel (CP)",1,1339,"Carboplatin","1","",28,3,"","",TRUE,"Cont.","14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;14.Carboplatin;0.Paclitaxel;7.Paclitaxel;7.Paclitaxel;","14.carboplatin;0.paclitaxel;7.paclitaxel;7.paclitaxel;"
